PATENT CLAIM ANALYSIS

Application Number: 15938961
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "130100"]

Abstract:
The present invention relates to anti-AXL antibodies, immunoconjugates, compositions and method of treatment of cancer with such anti-AXL antibodies, immunoconjugates, or compositions.

Claim (Index 21):
An antibody which binds to AXL and comprises a heavy chain variable region (VH) and a light chain variable region (VL), wherein the VH region comprises the amino acid sequence set forth in SEQ ID NO: 1, and the VL region comprises the amino acid sequence set forth in SEQ ID NO: 2.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.42105
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15325364', '15533049', '15318023', '15318028', '14355986']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7682412325966911
- 35 USC 102 Novelty (BERT): 0.6448234834940423
- Combined Prediction Score: 0.7558994576864262
- Mean Citation Score: 488.148804
- Max Citation Score: 670.65137
- Similarity Product: 548.6327670946085

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test